ASH in the news

ASH's analysis of the cost of smoking to society through healthcare, social care and fires were covered in detail in the Mirror.

ASH Chief Executive, Deborah Arnott, responds to the impact of spending cuts and deprivation on the UK government's 2030 smokefree ambition.

Deputy Chief Executive of ASH, Hazel Cheeseman, responds to the news that people with severe asthma and smokers who want to quit, may not get the drugs they need - a broken promise by ministers and the NHS.

Following new MHRA guidance on licensing of e-cigarettes, Chief Executive, Deborah Arnott, was quoted in the Telegraph, “The MHRA guidance opens the door to a day when smokers can be prescribed e-cigarettes to improve their chances of successfully quitting. “Just as the MHRA led the world in licensing vaccines for Covid-19, it is [now] leading the world by backing medicinal licensing of e-cigarettes.”

An article discussing the new MHRA guidance on e-cigarette licensing cites YouGov research conducted for ASH showing that the majority of E-cigarette users are current or former smokers.

ASH Chair, Professor Nick Hopkinson, discusses the new MHRA guidance on medical e-cigarette licensing for smoking cessation.

Deborah Arnott, Chief Executive of ASH, is quoted in the Financial Times discussing medical licensing for e-cigarettes.

ASH Chief Executive, Deborah Arnott, is quoted in the Daily Mail discussing the worrying rise in young smokers amidst the Covid-19 pandemic.

CEO, Deborah Arnott, appeared on BBC News to discuss Cancer Research UK/UCL findings on smoking rates increasing in young people during the Covid-19 pandemic.

ASH's and the APPG on Smoking and Health's recommendations for a smokefree 2030 are referenced in the Independent and other major national newspapers.